Breaking News on Global Pharmaceutical Technology & Manufacturing

News in brief

Gilead to close Colorado offices

13-Aug-2009

Related topics: Regulatory & Safety

Gilead Sciences is laying off up to 66 people as it closes its offices in Boulder and Westminster, Colorado, US to consolidate its operations in California.

The biotech has chosen to close the Colorado offices following the $1.4bn (€1bn) acquisition of California-based CV Therapeutics. This created an overlap in expertise that Gilead is resolving by closing the Colorado offices.

Gilead hopes to relocate 73 of the 139 staff that work in the Colorado offices. The offices will close at the end of 2009 or in the first two weeks of next year.

Copyright - Unless otherwise stated all contents of this web site are © 2012 - William Reed Business Media SAS - All Rights Reserved - For permission to reproduce any contents of this web site, please email our Syndication department copyright@wrbm.com - Full details for the use of materials on this site can be found in the Terms & Conditions

© 2012 - William Reed Business Media SAS - All rights reserved.